Sidmool Galatokside 100 Premium Functional Ampoule Skin Barrier Repair

Galatokside 100 Premium Functional Ampoule Skin Barrier Repair

Product details

Description

An ampoule-type essence focused on skin barrier care, used in the early stages of skincare after cleansing.

  • Its fluid texture spreads lightly over the entire face and absorbs without pilling or feeling heavy.
  • After absorption, it leaves skin looking smooth, clear, and refined.
  • It adheres comfortably when the skin is gently cupped with the hands.
  • Suitable for daily use on sensitive skin that is prone to becoming unsettled.

We strive to provide accurate product information. The information shown here was provided by the manufacturer, suppliers, and other sources and has not been verified by us. Please see our disclaimer.

How to use
1) After cleansing, refine the skin's texture with toner. 2) Apply an appropriate amount over the entire face. 3) Gently pat with your palms to help it absorb. 4) Finish with the next skincare step.
Brand / Product name
/ Galatokside 100 Premium Functional Ampoule Skin Barrier Repair

What's in it?

Based on the full ingredient list: Expected benefits 8 items

Based on the full ingredient list: Potential concerns 1 items

Key features

  • Alcohol-free
  • EU allergen-free
  • Fragrance-free
  • Oil-free
  • Paraben-free
  • Silicone-free
  • Sulfate-free
  • Reef-safe
  • Fungal acne-safe
Galatokside 100 Premium Functional Ampoule Skin Barrier Repair Find dupes

This information is based on the properties of individual ingredients in the full ingredient list and does not indicate the efficacy of the product itself or clinical results.

There are no survey responses for this product yet.

Ask the community

Viewduc users haven’t asked any questions about Galatokside 100 Premium Functional Ampoule Skin Barrier Repair yet.

Ratings & reviews

0
0 reviews
  • 5 stars, 0 reviews, 0%
  • 4 stars, 0 reviews, 0%
  • 3 stars, 0 reviews, 0%
  • 2 stars, 0 reviews, 0%
  • 1 stars, 0 reviews, 0%
This product has no reviews yet.